Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA0717341071
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -0.04 | |||||
Debt-to-Equity | -21.91 | |||||
Debt-to-EBITDA | 10.14 | |||||
Interest Coverage | 1.2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.06 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | -53.2 | |||||
3-Year FCF Growth Rate | -1.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 4 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.3 | |||||
9-Day RSI | 41.73 | |||||
14-Day RSI | 42.25 | |||||
6-1 Month Momentum % | 46.51 | |||||
12-1 Month Momentum % | 39.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.3 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 181.96 | |||||
Days Sales Outstanding | 76.56 | |||||
Days Payable | 82.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -12.47 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.78 | |||||
Operating Margin % | 18.25 | |||||
Net Margin % | -6.82 | |||||
FCF Margin % | 8.68 | |||||
ROA % | -2.27 | |||||
ROIC % | 10.71 | |||||
ROC (Joel Greenblatt) % | 45.44 | |||||
ROCE % | 4.21 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 2.41 | |||||
PS Ratio | 0.37 | |||||
Price-to-Free-Cash-Flow | 4.32 | |||||
Price-to-Operating-Cash-Flow | 3.17 | |||||
EV-to-EBIT | 26.28 | |||||
EV-to-Forward-EBIT | 12.69 | |||||
EV-to-EBITDA | 11.2 | |||||
EV-to-Forward-EBITDA | 6.38 | |||||
EV-to-Revenue | 2.82 | |||||
EV-to-Forward-Revenue | 2.62 | |||||
EV-to-FCF | 32.91 | |||||
Price-to-Projected-FCF | 0.55 | |||||
Price-to-Median-PS-Value | 0.4 | |||||
Earnings Yield (Greenblatt) % | 3.81 | |||||
FCF Yield % | 23.43 | |||||
Forward Rate of Return (Yacktman) % | 30.48 |